Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FolateScan in ovarian or endometrial carcinoma
NCT01689714Phase 2Completed
- Sponsor
- Endocyte
- Start
- Aug 2003
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of etarfolatide in ovarian carcinoma, endometrial carcinoma, sponsored by Endocyte. Started Aug 2003; status: completed.
02
Drugs
etarfolatide
03
Conditions
ovarian carcinomaendometrial carcinoma
Beyond the preview
Go deeper on NCT01689714.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01689714.